Literature DB >> 19936985

Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan.

M Osawa1, Y Ito, T Ishida, S Imai, S Ichiyama, M Mishima.   

Abstract

We established the distribution of amino acid alterations in quinolone resistance-determining regions (QRDRs) of Streptococcus pneumoniae isolates in Japan and described the correlation of these alterations with serotypes determined by multilocus sequencing typing. Among 141 S. pneumoniae isolates, five levofloxacin-resistant isolates harbored mutations in both gyrA and parC and/or parE and were clonally unrelated. Among 136 levofloxacin-susceptible isolates, one isolate (MIC = 2 mg/l) had a first-step parC mutation at Asp78. Twenty isolates had Lys137Asp in parC and Ile460Val in parE and contained nine serotypes and eight clonal complexes (CCs), including all eight Colombia(23F)-26 (CC138) isolates. Eighty-one isolates had Ile460Val in parE alone and contained 14 serotypes and 16 CCs, including 36 of 37 Netherlands(3)-31 (CC180) isolates and all 22 Taiwan(19F)-14 (CC271) isolates. In contrast, seven of ten Taiwan(23F)-15 (CC242) isolates were wild-type. Although each QRDR genotype contained various serotypes and CCs, prevalent clones were mostly associated with a single QRDR genotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936985     DOI: 10.1007/s10096-009-0832-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.

Authors:  Shantie Jagmohan-Changur; Taija Poikonen; Susa Vilkki; Virpi Launonen; Friedrik Wikman; Torben F Orntoft; Pål Møller; Hans Vasen; Carli Tops; Richard D Kolodner; Jukka-Pekka Mecklin; Heikki Järvinen; Stephen Bevan; Richard S Houlston; Lauri A Aaltonen; Riccardo Fodde; Juul Wijnen; Auli Karhu
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

2.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).

Authors:  Todd A Davies; Y Cheung Yee; Raul Goldschmidt; Karen Bush; Daniel F Sahm; Alan Evangelista
Journal:  J Antimicrob Chemother       Date:  2006-01-23       Impact factor: 5.790

4.  High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan.

Authors:  S Imai; Y Ito; T Ishida; T Hirai; I Ito; K Maekawa; S Takakura; Y Iinuma; S Ichiyama; M Mishima
Journal:  Clin Microbiol Infect       Date:  2009-08-20       Impact factor: 8.067

5.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

6.  Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.

Authors:  Heather J Adam; Kristen N Schurek; Kimberly A Nichol; Chris J Hoban; Trish J Baudry; Nancy M Laing; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

7.  Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.

Authors:  Nicole Wolter; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

8.  Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.

Authors:  Tadashi Ishida; Ko Maniwa; Hitoshi Kagioka; Masataka Hirabayashi; Koichi Onaru; Hiromi Tomioka; Michio Hayashi; Keisuke Tomii; Iwao Gohma; Yutaka Ito; Toyohiro Hirai; Isao Ito; Michiaki Mishima
Journal:  Respirology       Date:  2008-03       Impact factor: 6.424

9.  Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan.

Authors:  Y Ito; M Osawa; R Isozumi; S Imai; I Ito; T Hirai; T Ishida; S Ichiyama; M Mishima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

10.  Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.

Authors:  R Canton; M Morosini; M C Enright; I Morrissey
Journal:  J Antimicrob Chemother       Date:  2003-10-29       Impact factor: 5.790

  10 in total
  1 in total

1.  First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

Authors:  Vincent Cattoir; Alfred Kobal; Patrick Legrand
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.